Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.

Addus Homecare Corpo (ADUS) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart


See More
  • Market Capitalization, $K 400,090
  • Shares Outstanding, K 11,460
  • Annual Sales, $ 336,820 K
  • Annual Income, $ 11,620 K
  • 36-Month Beta 0.73
  • Price/Sales 1.01
  • Price/Book 2.57

Price Performance

See More
Period Period Low Period High Performance
33.20 +2.11%
on 01/12/17
36.40 -6.87%
on 01/04/17
-1.75 (-4.91%)
since 12/20/16
24.40 +38.93%
on 11/01/16
36.40 -6.87%
on 01/04/17
+6.93 (+25.70%)
since 10/20/16
15.33 +121.14%
on 03/24/16
36.40 -6.87%
on 01/04/17
+14.34 (+73.31%)
since 01/20/16

Most Recent Stories

More News
Luminex Projects Strong Q4 Revenues, Issues 2017 Guidance

Luminex Corporation (LMNX) announced that it expects revenues in the fourth quarter of 2016 to be approximately $72 million and approximately $271 million for full-year 2016.

PerkinElmer (PKI) to Acquire India-Based Tulip Diagnostics

PerkinElmer, Inc. (PKI) announced that it has entered into a definitive agreement to acquire Tulip Diagnostics Private Ltd.

Allscripts (MDRX) Q4 Bookings Likely to Hit Record Levels

Allscripts Healthcare Solutions Inc. (MDRX) recently provided a bullish update on bookings alongside providing a number of financial updates on fourth quarter 2016.

Air Methods (AIRM): Winter Hits December Passenger Count

Air Methods Corporation (AIRM), reported tepid preliminary patient transport and tourism passenger data for the month of Dec 2016.

AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View

AngioDynamics Inc. (ANGO) reported adjusted earnings of 19 cents per share in the second quarter of fiscal 2017 beating the Zacks Consensus Estimate by 3 cents.

Cerner Extends HNM Partnership with University of Missouri

Cerner Corporation (CERN) and the University of Missouri Health Care announced that they have inked an agreement to extend their partnership.

Alere Forensic Toxicology Division Gets ABFT Accreditation

Alere Inc. (ALR), a leading player in rapid diagnostic tests, announced that its forensic toxicology division has received accreditation from the American Board of Forensic Toxicology.

Luminex (LMNX) Gets FDA Clearance for ARIES GBS Assay

Luminex Corporation (LMNX) announced that it has received FDA clearance for the ARIES Group B Streptococcus Assay for antepartum detection of GBS colonization.

Mazor Robotics (MZOR) Receives 21 System Orders in Q4

Israel-based developer of robotic technology and products, Mazor Robotics Ltd. (MZOR), recently announced the receipt of 21 surgical guidance system orders in fourth-quarter 2016.

Cerner Hurt by Low System Sales and Intense Competition

On Jan 3, we issued an updated research report on North Kansas City, MO-based Cerner Corporation (CERN).

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company's services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special...

See More

Support & Resistance

2nd Resistance Point 34.53
1st Resistance Point 34.22
Last Price 33.90
1st Support Level 33.47
2nd Support Level 33.03

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.